Netarsudil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 220 publications
METTL7B Mitigates Hypertension and Vascular Remodeling.
Journal: Circulation
Published: August 25, 2026
Preparation of a new fixed-combination carteolol-netarsudil ophthalmic solution via one-pot pH-adjusting solubilization strategy for glaucoma treatment.
Journal: Drug delivery
Published: August 15, 2026
Targeting RhoA/ROCK Signaling to Modulate Extracellular Matrix Remodeling in Corneal Endothelial Dystrophies.
Journal: Investigative ophthalmology & visual science
Published: August 13, 2026
Pilot Clinical Trial of Topical Netarsudil to Lower Risk of Proliferative Vitreoretinopathy in High-Risk Primary Retinal Detachment.
Journal: Journal of vitreoretinal diseases
Published: August 08, 2026
Drug-associated lacrimal drainage obstruction: a population-based pharmacovigilance study.
Journal: Orbit (Amsterdam, Netherlands)
Published: July 06, 2026
Longitudinal Structural and Functional Trajectories Following Netarsudil Intensification or Surgical Escalation in Primary Open-Angle Glaucoma.
Journal: Seminars in ophthalmology
Published: July 03, 2026
The effects of netarsudil ophthalmic solution on the expression of genes involved in fibrogenesis in orbital fibroblasts of patients with thyroid eye disease.
Journal: Molecular biology reports
Published: April 15, 2026
Persistent Epithelial Defect After Bullae Rupture With Netarsudil.
Journal: Cureus
Published: April 10, 2026
Re-Purposing a Rho-Associated Coiled-Coil Kinase (ROCK) Inhibitor for Alzheimer's Disease.
Journal: Journal of clinical medicine
Published: March 23, 2026
Last Updated: 09/26/2026